This Healthcare Stock is Down By More Than 50%: Here's 25 Stocks Moving Premarket

Gainers

  • Minim, Inc. MINM rose 42.8% to $0.52 in pre-market trading. Minim recently said Nicole Hayward Zheng will be transitioning from her role as President and Chief Marketing Officer to pursue a new career opportunity with a privately-held company in a new field.
  • TDH Holdings, Inc. PETZ rose 31.4% to $2.71 in pre-market trading. TDH Holdings reported in SEC filing that the company withdraws of registration statement.
  • Staffing 360 Solutions, Inc. STAF rose 16.5% to $4.60 in pre-market trading. Staffing 360 Solutions reported closing of $4 million private placement priced at-the-market under Nasdaq rules.
  • Sharps Technology, Inc. STSS rose 16.1% to $1.30 in pre-market trading after dipping around 7% on Tuesday.
  • SaverOne 2014 Ltd SVRE rose 12% to $2.80 in pre-market trading. SaverOne 2014 recently named Israel Eybi as Chief Marketing and Sales Officer.
  • Stitch Fix, Inc. SFIX rose 9.9% to $5.65 in pre-market trading after an SEC filing showed that Benchmark's Bill Gurley bought 1 million shares of the personal style service company.
  • ABVC BioPharma, Inc. ABVC rose 9.5% to $1.01 in pre-market trading after declining around 4% on Tuesday.
  • Cyclacel Pharmaceuticals, Inc. CYCC rose 9.2% to $1.30 in pre-market trading. Cyclacel Pharmaceuticals recently said it is adding two dose levels in a protocol amendment to test higher doses of oral fadraciclib before determining the recommended Phase 2 dose anticipated in 2H of 2022, citing the absence of dose-limiting toxicities.
  • Borqs Technologies, Inc. BRQS rose 9% to $1.81 in pre-market trading. Borqs Technologies recently announced its subsidiary, Holu Hou Energy, signed $49.8 million of contracts in Q2 in the State of Hawaii.
  • BiomX Inc. PHGE rose 8.7% to $1.07 in pre-market trading after jumping around 14% on Tuesday. BiomX recently reported voluntary delisting from the Tel Aviv Stock Exchange.
  • Canoo Inc. GOEV rose 8.5% to $3.94 in pre-market trading. Canoo shares jumped 53% on Tuesday after Walmart signed a definitive agreement with the company to purchase 4,500 all-electric delivery vehicles, beginning with the Lifestyle Delivery Vehicle, with the option to purchase up to 10,000 units.
  • Inpixon INPX rose 7.5% to $0.1784 in pre-market trading after declining 15% on Tuesday.
  • Waitr Holdings Inc. WTRH rose 6.1% to $0.3430 in pre-market trading after dipping 21% on Tuesday. Waitr recently announced a new partnership with Burq to allow deliveries from several new retail industries.

Don’t forget to check out our premarket coverage here .

Losers

  • Humanigen, Inc. HGEN fell 52.2% to $1.43 in pre-market trading after the company received preliminary topline data from NIH/NIAID study of Lenzilumab in ACTIV-5/BET-B.
  • Applied Genetic Technologies Corporation AGTC shares fell 46% to $0.4579 in pre-market trading after the company reported pricing of $10 million underwritten public offering.
  • EZFill Holdings Inc. EZFL fell 39.4% to $0.37 in pre-market trading after dipping around 8% on Tuesday. EzFill Holdings expanded its fleet to 31 operating delivery vehicles, with nine additional vehicles in production.
  • Atara Biotherapeutics, Inc. ATRA fell 35.5% to $5.58 in pre-market trading. Atara Biotherapeutics announced completion of the ATA188 Phase 2 EMBOLD study interim analysis in patients with progressive MS.
  • Guardforce AI Co., Limited GFAI fell 14.2% to $0.3742 in pre-market trading after the company entered into warrant exercise transaction for $1.33 million in gross proceeds.
  • Aclarion, Inc. ACON fell 13.8% to $0.87 in pre-market trading after jumping around 23% on Tuesday.
  • VBI Vaccines Inc. VBIV fell 12.5% to $0.94 in pre-market trading. -VBI Vaccines named John Dillman as Chief Commercial Officer.
  • Ampio Pharmaceuticals, Inc. AMPE fell 10.8% to $0.1550 in pre-market trading.
  • Histogen Inc. HSTO shares fell 8.5% to $3.44 in pre-market trading. Histogen announced a $5 million private placement priced at-the-market under Nasdaq rules.
  • Romeo Power, Inc. RMO fell 7.7% to $0.5815 in pre-market trading after jumping 26% on Tuesday.
  • Rhythm Pharmaceuticals, Inc. RYTM fell 7.1% to $6.20 in pre-market trading. Rhythm Pharmaceuticals shares climbed 42% on Tuesday after the company announced interim results from a Phase 2 trial of setmelanotide for severe obesity and hyperphagia, which showed a 17.2% mean reduction in BMI at 16 weeks.
  • Greenwich LifeSciences, Inc. GLSI shares fell 6.6% to $11.19 in pre-market trading. Greenwich LifeSciences shares jumped 39% on Tuesday after the FDA removed the clinical hold on the company's Flamingo-01 Phase 3 trial of GP2.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!